Di Nuzzo Private Wealth, Inc. Procept Bio Robotics Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $697 Million
- Q3 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 63 shares of PRCT stock, worth $1,971. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 63
-0.0%
Holding current value
$1,971
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
284Shares Held
45MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$164 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$109 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$67.5 Million0.04% of portfolio
-
Chicago Capital, LLC1.57MShares$49.1 Million1.39% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$47.8 Million0.06% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.4B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...